Publication Date:
1990-09-21
Description:
Although it is known that Parkinson's disease results from a loss of dopaminergic neurons in the substantia nigra, the resulting alterations in activity in the basal ganglia responsible for parkinsonian motor deficits are still poorly characterized. Recently, increased activity in the subthalamic nucleus has been implicated in the motor abnormalities. To test this hypothesis, the effects of lesions of the subthalamic nucleus were evaluated in monkeys rendered parkinsonian by treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The lesions reduced all of the major motor disturbances in the contralateral limbs, including akinesia, rigidity, and tremor. This result supports the postulated role of excessive activity in the subthalamic nucleus in Parkinson's disease.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Bergman, H -- Wichmann, T -- DeLong, M R -- S RO1 NS15412-09/NS/NINDS NIH HHS/ -- New York, N.Y. -- Science. 1990 Sep 21;249(4975):1436-8.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Neurology, Johns Hopkins Hospital, Baltimore, MD 21205.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/2402638" target="_blank"〉PubMed〈/a〉
Keywords:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
;
Animals
;
Brain/physiology/physiopathology
;
Cercopithecus aethiops
;
Disease Models, Animal
;
Ibotenic Acid/pharmacology/therapeutic use
;
Models, Neurological
;
Parkinson Disease/physiopathology/*therapy
;
Parkinson Disease, Secondary/chemically induced
;
Periaqueductal Gray/drug effects/physiology/*physiopathology
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink